Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
18.86
+0.21 (1.13%)
At close: Jun 23, 2026, 4:00 PM EDT
18.62
-0.24 (-1.27%)
After-hours: Jun 23, 2026, 7:21 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.95 billion as of June 23, 2026. Its market cap has increased by 100.17% in one year.
Market Cap
1.95B
Enterprise Value
1.49B
1-Year Change
100.17%
Ranking
Category
Stock Price
$18.86
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.95B, an increase of 176.99%. That is a compound annual growth rate of 18.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 1.95B | 1.42% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 1.93B |
| Lakefront Biotherapeutics NV | 1.86B |
| Generate Biomedicines | 1.86B |
| Sarepta Therapeutics | 1.85B |
| Taysha Gene Therapies | 1.84B |
| Viridian Therapeutics | 1.84B |
| Rapport Therapeutics | 1.79B |
| Nanobiotix | 1.76B |